Fasting plasma lactate as a possible early clinical marker for metabolic disease risk.
Broskey NT, Pories WJ, DeMaria EJ, Jones TE, Tanner CJ, Zheng D, Krassovskaia PM, Mitchell LA, Matarese LE, O'Brien KF, Cortright RN, Dohm GL, Houmard JA.
Broskey NT, et al. Among authors: krassovskaia pm.
Diabetes Metab Syndr. 2024 Feb;18(2):102955. doi: 10.1016/j.dsx.2024.102955. Epub 2024 Jan 29.
Diabetes Metab Syndr. 2024.
PMID: 38310736